With OdySight Care™, patients can test their visual acuity autonomously and remotely between visits for a clinical trial. The investigator accesses additional valuable data to contextualize the data collected during the visits and strengthen his data set.
Visual acuity assessment is an efficacy measurement in most retinal diseases trials, and also a safety measurement in FOTE (front of the eye) trials, along with trials in neurology (i.e multiple sclerosis) and oncology.
OdySight Care™ is based on a patented technology with a face detection module that allows the app to control the test conditions and thus ensure results comparable to those obtained in a center*.
Over 150,000 visual tests have been performed with this technology by more than 3,000 patients**.
A home-testing app for visual acuity: the case of clinical trials
*Brucker et al, 2019
** Internal Tilak Healthcare Data on OdySight® (OdySight is a medical device based on the same patented technology). More information available here: odysight.app
Visual acuity testing can also be applied to every area in need for punctual vision checks, such as residents home, health insurances, labor medicine.
Leverage an existing platform specialized in retinal diseases